Natural Killer (NK) Cell Therapeutics-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data

Table Of Contents

Chapter 1 Overview of Natural Killer (NK) Cell Therapeutics 1.1 Definition of Natural Killer (NK) Cell Therapeutics in This Report 1.2 Commercial Types of Natural Killer (NK) Cell Therapeutics 1.2.1 Mogamulizumab 1.2.2 Lorvotuzumab Mertansine 1.2.3 Others 1.3 Downstream Application of Natural Killer (NK) Cell Therapeutics 1.3.1 Cancer 1.3.2 Cardiovascular Diseases 1.3.3 Others 1.4 Development History of Natural Killer (NK) Cell Therapeutics 1.5 Market Status and Trend of Natural Killer (NK) Cell Therapeutics 2015-2026 1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Status and Trend 2015-2026 1.5.2 Regional Natural Killer (NK) Cell Therapeutics Market Status and Trend 2015-2026Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Natural Killer (NK) Cell Therapeutics 2015-2019 2.2 Sales Market of Natural Killer (NK) Cell Therapeutics by Regions 2.2.1 Sales Volume of Natural Killer (NK) Cell Therapeutics by Regions 2.2.2 Sales Value of Natural Killer (NK) Cell Therapeutics by Regions 2.3 Production Market of Natural Killer (NK) Cell Therapeutics by Regions 2.4 Global Market Forecast of Natural Killer (NK) Cell Therapeutics 2020-2026 2.4.1 Global Market Forecast of Natural Killer (NK) Cell Therapeutics 2020-2026 2.4.2 Market Forecast of Natural Killer (NK) Cell Therapeutics by Regions 2020-2026Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Natural Killer (NK) Cell Therapeutics by Types 3.2 Sales Value of Natural Killer (NK) Cell Therapeutics by Types 3.3 Market Forecast of Natural Killer (NK) Cell Therapeutics by TypesChapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Natural Killer (NK) Cell Therapeutics by Downstream Industry 4.2 Global Market Forecast of Natural Killer (NK) Cell Therapeutics by Downstream IndustryChapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Natural Killer (NK) Cell Therapeutics Market Status by Countries 5.1.1 North America Natural Killer (NK) Cell Therapeutics Sales by Countries (2015-2019) 5.1.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2019) 5.1.3 United States Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 5.1.4 Canada Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 5.1.5 Mexico Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 5.2 North America Natural Killer (NK) Cell Therapeutics Market Status by Manufacturers 5.3 North America Natural Killer (NK) Cell Therapeutics Market Status by Type (2015-2019) 5.3.1 North America Natural Killer (NK) Cell Therapeutics Sales by Type (2015-2019) 5.3.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2015-2019) 5.4 North America Natural Killer (NK) Cell Therapeutics Market Status by Downstream Industry (2015-2019)Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Natural Killer (NK) Cell Therapeutics Market Status by Countries 6.1.1 Europe Natural Killer (NK) Cell Therapeutics Sales by Countries (2015-2019) 6.1.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2019) 6.1.3 Germany Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 6.1.4 UK Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 6.1.5 France Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 6.1.6 Italy Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 6.1.7 Russia Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 6.1.8 Spain Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 6.1.9 Benelux Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 6.2 Europe Natural Killer (NK) Cell Therapeutics Market Status by Manufacturers 6.3 Europe Natural Killer (NK) Cell Therapeutics Market Status by Type (2015-2019) 6.3.1 Europe Natural Killer (NK) Cell Therapeutics Sales by Type (2015-2019) 6.3.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2015-2019) 6.4 Europe Natural Killer (NK) Cell Therapeutics Market Status by Downstream Industry (2015-2019)Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Market Status by Countries 7.1.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Countries (2015-2019) 7.1.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2019) 7.1.3 China Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 7.1.4 Japan Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 7.1.5 India Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 7.1.6 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 7.1.7 Australia Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 7.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Market Status by Manufacturers 7.3 Asia Pacific Natural Killer (NK) Cell Therapeutics Market Status by Type (2015-2019) 7.3.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Sales by Type (2015-2019) 7.3.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2015-2019) 7.4 Asia Pacific Natural Killer (NK) Cell Therapeutics Market Status by Downstream Industry (2015-2019)Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Natural Killer (NK) Cell Therapeutics Market Status by Countries 8.1.1 Latin America Natural Killer (NK) Cell Therapeutics Sales by Countries (2015-2019) 8.1.2 Latin America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2019) 8.1.3 Brazil Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 8.1.4 Argentina Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 8.1.5 Colombia Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 8.2 Latin America Natural Killer (NK) Cell Therapeutics Market Status by Manufacturers 8.3 Latin America Natural Killer (NK) Cell Therapeutics Market Status by Type (2015-2019) 8.3.1 Latin America Natural Killer (NK) Cell Therapeutics Sales by Type (2015-2019) 8.3.2 Latin America Natural Killer (NK) Cell Therapeutics Revenue by Type (2015-2019) 8.4 Latin America Natural Killer (NK) Cell Therapeutics Market Status by Downstream Industry (2015-2019)Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Status by Countries 9.1.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Countries (2015-2019) 9.1.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2019) 9.1.3 Middle East Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 9.1.4 Africa Natural Killer (NK) Cell Therapeutics Market Status (2015-2019) 9.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Status by Manufacturers 9.3 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Status by Type (2015-2019) 9.3.1 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales by Type (2015-2019) 9.3.2 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2015-2019) 9.4 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Status by Downstream Industry (2015-2019)Chapter 10 Market Driving Factor Analysis of Natural Killer (NK) Cell Therapeutics 10.1 Global Economy Situation and Trend Overview 10.2 Natural Killer (NK) Cell Therapeutics Downstream Industry Situation and Trend OverviewChapter 11 Natural Killer (NK) Cell Therapeutics Market Competition Status by Major Manufacturers 11.1 Production Volume of Natural Killer (NK) Cell Therapeutics by Major Manufacturers 11.2 Production Value of Natural Killer (NK) Cell Therapeutics by Major Manufacturers 11.3 Basic Information of Natural Killer (NK) Cell Therapeutics by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Natural Killer (NK) Cell Therapeutics Major Manufacturer 11.3.2 Employees and Revenue Level of Natural Killer (NK) Cell Therapeutics Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and LaunchChapter 12 Natural Killer (NK) Cell Therapeutics Major Manufacturers Introduction and Market Data 12.1 Chipscreen Biosciences 12.1.1 Company profile 12.1.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.1.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences 12.2 Bristol-Myers Squibb 12.2.1 Company profile 12.2.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.2.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb 12.3 Innate Pharma 12.3.1 Company profile 12.3.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.3.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Innate Pharma 12.4 Affimed NV 12.4.1 Company profile 12.4.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.4.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Affimed NV 12.5 NantKwest 12.5.1 Company profile 12.5.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.5.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of NantKwest 12.6 Altor BioScience 12.6.1 Company profile 12.6.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.6.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Altor BioScience 12.7 Henry Ford Health Services 12.7.1 Company profile 12.7.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.7.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Henry Ford Health Services 12.8 Sorrento Therapeutics 12.8.1 Company profile 12.8.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.8.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Sorrento Therapeutics 12.9 Takeda 12.9.1 Company profile 12.9.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.9.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of Takeda 12.10 NKT 12.10.1 Company profile 12.10.2 Representative Natural Killer (NK) Cell Therapeutics Product 12.10.3 Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin of NKTChapter 13 Upstream and Downstream Market Analysis of Natural Killer (NK) Cell Therapeutics 13.1 Industry Chain of Natural Killer (NK) Cell Therapeutics 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies AnalysisChapter 14 Cost and Gross Margin Analysis of Natural Killer (NK) Cell Therapeutics 14.1 Cost Structure Analysis of Natural Killer (NK) Cell Therapeutics 14.2 Raw Materials Cost Analysis of Natural Killer (NK) Cell Therapeutics 14.3 Labor Cost Analysis of Natural Killer (NK) Cell Therapeutics 14.4 Manufacturing Expenses Analysis of Natural Killer (NK) Cell TherapeuticsChapter 15 Report ConclusionChapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference